Robeco Institutional Asset Management Reduces Elevance Health Stake

Asset manager cuts position in health insurance company by nearly half in Q4 2025

Apr. 15, 2026 at 9:49am

Got story updates? Submit your updates here. ›

An extreme close-up of intricate, metallic banking machinery and mechanisms, conveying the secure, institutional nature of the financial sector without using any text or identifiable elements.A reduction in institutional investment in a major health insurance provider could signal broader shifts in the industry.Indianapolis Today

Robeco Institutional Asset Management B.V. reduced its stake in Elevance Health, Inc. (NYSE: ELV) by 47% in the fourth quarter of 2025, according to a recent 13F filing with the Securities and Exchange Commission. The firm now owns 30,898 shares of the health insurance company's stock, down from 58,260 shares previously.

Why it matters

Elevance Health is one of the largest health benefits companies in the United States, providing medical and specialty health plans for individuals, employers, and government programs. Institutional investors closely monitor changes in ownership of major healthcare stocks like Elevance as an indicator of market sentiment and potential performance.

The details

Robeco Institutional Asset Management, a global asset management firm, sold 27,362 shares of Elevance Health stock during the fourth quarter. The firm's remaining 30,898 shares were worth approximately $10.8 million at the end of the quarter. Other hedge funds have also adjusted their Elevance Health positions, with some increasing and others decreasing their stakes in the company.

  • Robeco Institutional Asset Management reduced its Elevance Health stake in Q4 2025.

The players

Robeco Institutional Asset Management B.V.

A global asset management firm that reduced its stake in Elevance Health by 47% in Q4 2025.

Elevance Health, Inc.

A large U.S. health benefits company that provides medical and specialty health plans for individuals, employers, and government programs.

Got photos? Submit your photos here. ›

The takeaway

The reduction in Robeco's Elevance Health position suggests some institutional investors may be taking a more cautious view on the health insurance sector, though the overall market sentiment remains mixed. Elevance's performance and strategic direction will continue to be closely watched by analysts and investors.